Phase Ii Study Of Talazoparib, A Parp Inhibitor, In Somatic Brca1/2 Mutant Metastatic Breast CancerNeelima Vidula,Nora Horick,Erin Basile,Erica Blouch,Leif W. Ellisen,Hope S. Rugo,Aditya BardiaCANCER RESEARCH(2021)引用 1|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要